Literature DB >> 21569804

Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.

Yinghuan Li1, Jie Wang, M Guillaume Wientjes, Jessie L-S Au.   

Abstract

Advances in molecular medicines have led to identification of promising targets on cellular and molecular levels. These targets are located in extracellular and intracellular compartments. The latter include cytosol, nucleus, mitochondrion, Golgi apparatus and endoplasmic reticulum. This report gives an overview on the barriers to delivering nanomedicines to various target sites within a solid tumor, the experimental approaches to overcome such barriers, and the potential utility of nanotechnology. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21569804      PMCID: PMC3378679          DOI: 10.1016/j.addr.2011.04.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  157 in total

Review 1.  Gatekeepers of the nucleus.

Authors:  S R Wente
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

2.  Targeted drug delivery to C6 glioma by transferrin-coupled liposomes.

Authors:  D A Eavarone; X Yu; R V Bellamkonda
Journal:  J Biomed Mater Res       Date:  2000-07

3.  Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

Authors:  D Goren; A T Horowitz; D Tzemach; M Tarshish; S Zalipsky; A Gabizon
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

Review 4.  Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil.

Authors:  M Rao; C R Alving
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

5.  Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer.

Authors:  Christian Bode; Lutz Trojan; Christel Weiss; Bettina Kraenzlin; Uwe Michaelis; Michael Teifel; Peter Alken; Maurice Stephan Michel
Journal:  Oncol Rep       Date:  2009-08       Impact factor: 3.906

6.  Effect of polyethyleneglycol spacer on the binding properties of nuclear localization signal-modified liposomes to isolated nucleus.

Authors:  Dai Kurihara; Hidetaka Akita; Asako Kudo; Tomoya Masuda; Shiroh Futaki; Hideyoshi Harashima
Journal:  Biol Pharm Bull       Date:  2009-07       Impact factor: 2.233

Review 7.  Recent progress in tumor pH targeting nanotechnology.

Authors:  Eun Seong Lee; Zhonggao Gao; You Han Bae
Journal:  J Control Release       Date:  2008-05-10       Impact factor: 9.776

8.  Ligands for mapping alphavbeta3-integrin expression in vivo.

Authors:  Margret Schottelius; Burkhardt Laufer; Horst Kessler; Hans-Jürgen Wester
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

9.  Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo.

Authors:  Vikash P Chauhan; Ryan M Lanning; Benjamin Diop-Frimpong; Wilson Mok; Edward B Brown; Timothy P Padera; Yves Boucher; Rakesh K Jain
Journal:  Biophys J       Date:  2009-07-08       Impact factor: 4.033

10.  Vascular permeability in a human tumour xenograft: molecular charge dependence.

Authors:  M Dellian; F Yuan; V S Trubetskoy; V P Torchilin; R K Jain
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  53 in total

Review 1.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

Review 2.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.

Authors:  Lei Miao; C Michael Lin; Leaf Huang
Journal:  J Control Release       Date:  2015-08-12       Impact factor: 9.776

3.  Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.

Authors:  Yaqin Zhu; Liang Cheng; Lifang Cheng; Fazhen Huang; Qing Hu; Ling Li; Chenmin Tian; Lin Wei; Dawei Chen
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

Review 4.  Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products.

Authors:  Jessie L-S Au; Ze Lu; Roberto A Abbiati; M Guillaume Wientjes
Journal:  AAPS J       Date:  2019-02-01       Impact factor: 4.009

Review 5.  Biomolecular engineering for nanobio/bionanotechnology.

Authors:  Teruyuki Nagamune
Journal:  Nano Converg       Date:  2017-04-24

6.  Targeting gallbladder cancer: hyaluronan sensitizes cancer cells to chemo-therapeutics.

Authors:  Mingzhe Ma; Mingzhe Weng; Mingdi Zhang; Yiyu Qin; Wei Gong; Zhiwei Quan
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

7.  Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.

Authors:  Samuel V Mussi; Rupa Sawant; Federico Perche; Mônica C Oliveira; Ricardo B Azevedo; Lucas A M Ferreira; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2014-02-13       Impact factor: 4.200

8.  Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential.

Authors:  Nishi Mody; Rakesh Kumar Tekade; Neelesh Kumar Mehra; Prashant Chopdey; Narendra Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2014-01-16       Impact factor: 3.246

9.  Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates.

Authors:  Fengxi Liu; Min Li; Chunxi Liu; Yongjun Liu; Yanchao Liang; Fengshan Wang; Na Zhang
Journal:  Pharm Res       Date:  2013-09-17       Impact factor: 4.200

10.  Predicting diffusive transport of cationic liposomes in 3-dimensional tumor spheroids.

Authors:  Michael G Wientjes; Bertrand Z Yeung; Ze Lu; M Guillaume Wientjes; Jessie L S Au
Journal:  J Control Release       Date:  2014-07-02       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.